Long-term (96 weeks) adefovir dipivoxil in HBeAg negative chronic hepatitis results in significant virological, biochemical and histological improvement.

被引：0
|
作者：
Hadziyannis, S
Tassopoulos, N
Heathcote, E
Chang, TT
Kitis, G
Rizzeto, M
Marcellin, P
Lim, SG
Chen, SS
Wulfsohn, M
Xiong, S
James, C
Currie, G
Brosgart, C
机构：
[1] Henry Dunant Hosp, Athens, M5T 2S8, Greece
[2] Western Attica Hosp, Athens, Greece
[3] Toronto Western Hosp, Toronto, ON, Canada
[4] Natl Cheng Kung Hosp, Taipei, Taiwan
[5] Georgios Papanikolaou Hosp, Thessaloniki, Greece
[6] Azienda Ospedaliera San Giovanni Battista, Turin 117548, Italy
[7] Hop Beaujon, Clichy, 94404, France
[8] Natl Univ Singapore, Singapore, Singapore
[9] Gilead Sci Inc, Foster City, CA USA
来源：
HEPATOLOGY | 2003年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
241
引用
收藏
页码：273A / 273A
页数：1
相关论文
共 50 条
  • [1] Long-term therapy with adefovir dipivoxil for HBeAg positive chronic hepatitis B: results from 144 weeks adefovir dipivoxil treatment
    You, J.
    Zhuang, L.
    Chen, H. Y.
    Feng, X.
    Kong, L.
    Lei, H.
    Ma, Y. L.
    Li, Y. L.
    Yang, W. B.
    Huang, J. H.
    Yan, S. M.
    Che, Y. H.
    Wang, Q. Q.
    Chen, L.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S30 - S30
  • [2] Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B
    Hadziyannis, SJ
    Tassopoulos, NC
    Heathcote, EJ
    Chang, TT
    Kitis, G
    Rizzetto, M
    Marcellin, P
    Lim, SG
    Goodman, Z
    Ma, J
    Arterburn, S
    Xiong, S
    Currie, G
    Brosgart, CL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (26): : 2673 - 2681
  • [3] Long term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B
    Bhushan, B.
    [J]. JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S95 - S95
  • [4] Virological response to adefovir dipivoxil predicts the long-term development of resistance in previously untreated patients with HBeAg-negative chronic hepatitis B
    Suarez, Emilio
    Gila, Ana
    Figueruela, Blanca
    Chueca, Natalia
    Munoz Rueda, Pilar
    Puche, Beatriz
    Fraga, Enrique
    Garcia, Federico
    Manuel Martin, Juan
    Andrade, Raul J.
    Nogales, Carmen
    Romero-Gomez, Manuel
    Salmeron, Javier
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2011, 34 (02): : 69 - 74
  • [5] Histological improvement in HBeAg positive chronic hepatitis B patients treated with adefovir dipivoxil
    Marcellin, P
    Goodman, Z
    Chang, TT
    Lim, SG
    Tong, MR
    Sievert, W
    Shiffman, M
    Jeffers, L
    Wulfsohn, M
    Fallis, R
    Fry, J
    Brosgart, C
    [J]. JOURNAL OF HEPATOLOGY, 2002, 36 : 8 - 8
  • [6] Long-term therapy with adefovir dipivoxil for HBeAg positive chronic hepatitis B patients with various baseline biochemical levels: Results from 4 years adefovir dipivoxil treatment
    Zhuang, L.
    You, J.
    Kong, L.
    Li, Y. L.
    Lei, H.
    Ma, Y. L.
    Chen, H. Y.
    Liu, H. E.
    Feng, X.
    Ma, S. J.
    Huang, J. H.
    Che, Y. H.
    Wang, Q. Q.
    Chen, L.
    Yan, S. M.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 319 - 319
  • [7] Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years
    Hadziyannis, Stephanos J.
    Tassopoulos, Nicolaos C.
    Heathcote, E. Jenny
    Chang, Ting-Tsung
    Kitis, George
    Rizzetto, Mario
    Marcellin, Patrick
    Lik, Seng Gee
    Goodman, Zachary
    Ma, Jia
    Brosgart, Carol L.
    Eorroto-Esoda, Katyna
    Arterburn, Sarah
    Chuck, Steven L.
    [J]. GASTROENTEROLOGY, 2006, 131 (06) : 1743 - 1751
  • [8] Efficacy of 96 weeks adefovir dipivoxil treatment in HBeAg positive chronic hepatitis B patients with various baseline biochemical levels
    Zhuang, L.
    You, J.
    Kong, L.
    Lei, H.
    Yang, R. -D
    Zhang, X.
    Wang, Q. -Q
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E236 - E237
  • [9] 48 weeks of adefovir dipivoxil (ADV) results in a consistent and significant improvement in liver histology and virological status regardless of baseline knodell fibrosis score in patients with HBeAg-chronic hepatitis B.
    Marcellin, P
    Hadziyannis, S
    Tassopoulos, N
    Heathcote, E
    Chang, TT
    Kitis, G
    Rizzetto, M
    Goodman, Z
    Chen, SS
    Wulfsohn, M
    Wollman, M
    James, C
    Brosgart, C
    [J]. HEPATOLOGY, 2003, 38 (04) : 713A - 713A
  • [10] EFFECTIVENESS OF LONG-TERM COMBINATION THERAPY WITH ADEFOVIR DIPIVOXIL AND LAMIVUDINE IN PATIENTS WITH HBEAG-NEGATIVE CHRONIC HEPATITIS B AND LAMIVUDINE RESISTANCE
    Manolakopoulos, Spilios
    Striki, Athanasia
    Papatheodoridis, George V.
    Deutsch, Melanie
    Mela, Maria
    Tzourmakliotis, Dimitrios
    Manesis, Emanuel K.
    Archimandritis, Athanasios J.
    [J]. HEPATOLOGY, 2009, 50 (04) : 520A - 521A
12345